Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice

Meritxell Morró1,2,3, Laia Vilà1,3, Sylvie Franckhauser1,3

  • 1Center of Animal Biotechnology and Gene Therapy, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Diabetes
|February 23, 2020
PubMed

Insights

Vitamin D receptor (VDR) plays a crucial role in pancreatic beta-cells, protecting against diabetes. Maintaining VDR levels in beta-cells preserves their mass and function, offering protection from diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Diseases

Background:

  • Vitamin D deficiency is linked to increased diabetes incidence in humans and animal models.
  • Vitamin D receptor (VDR) gene polymorphisms are associated with diabetes, but its specific role in pancreatic beta-cells remains unclear.

Purpose of the Study:

  • To investigate the role of the vitamin D receptor (VDR) in pancreatic beta-cells concerning the pathophysiology of diabetes.
  • To elucidate the impact of VDR modulation on beta-cell function and diabetes development.

Main Methods:

  • Studied VDR expression in pancreatic islets from healthy and diabetic mouse models (type 1 and type 2 diabetes).
  • Utilized transgenic mice overexpressing VDR specifically in beta-cells.
  • Assessed protection against streptozotocin-induced diabetes, beta-cell mass, and islet inflammation.

Main Results:

  • VDR expression in islets was modulated by glucose and decreased in diabetic mouse models.
  • Overexpression of VDR in beta-cells protected mice against streptozotocin-induced diabetes.
  • VDR overexpression preserved beta-cell mass and reduced islet inflammation.

Conclusions:

  • Sustained VDR levels in pancreatic beta-cells are critical for maintaining beta-cell mass and function.
  • VDR in beta-cells plays a protective role against diabetes development.
  • Targeting VDR may offer a therapeutic strategy for diabetes prevention and management.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
761
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.4K